rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Rediff News  All News 

Central Drugs Standard Control Organisation

Rediff.com  »  News  »   Central Drugs Standard Control Organisation

  News for Central Drugs Standard Control Organisation

  • News
  • Business

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

India's drug regulator has granted restricted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in......

Covishield, Covaxin get regular market approval

India's drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said.......

Govt panel recommends regular market approval for Covishield, Covaxin

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain......

Human trials of India's 1st mRNA vaccine to start in February

The country's first messenger mRNA vaccine is expected to begin trials on humans in February. IMAGE: A health worker administers a dose of COVID-19 vaccine to a beneficiary during a vaccination......

COVID-19: Mistakes World Must Avoid

If the pandemic persists, at least a portion of the blame should go to greed and nationalism that got in the way of the world acting together, notes Prosenjit Datta. IMAGE: A vaccination drive at......

Govt caps trade margin on oxygen concentrators at 70%

The government has capped the trade margin on oxygen concentrators at 70 per cent in order to keep in check the price of the much in demand critical life saving component amid the second wave of......

How complex is the process of getting approval for a vaccine?

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......

Every 3rd tablet in the US market is from India

India lost its competitive advantage as China gave fiscal benefits to its local manufacturers. Besides, recent policy flip-flops have, however, dented India’s image as the ‘pharmacy of......

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z